Global X China Biotech UCITS ETF USD Accumulating (CBI0.DE)
CBI0.DE is a passive ETF by Global X tracking the investment results of the Solactive China Biotech. CBI0.DE launched on Jan 18, 2022 and has a 0.68% expense ratio.
ETF Info
| ISIN | IE0004LIBFM2 |
|---|---|
| WKN | A3C5RY |
| Issuer | Global X |
| Inception Date | Jan 18, 2022 |
| Category | Health & Biotech Equities |
| Index Tracked | Solactive China Biotech |
| Domicile | Ireland |
| Distribution Policy | Accumulating |
| Asset Class | Equity |
Expense Ratio
CBI0.DE has a high expense ratio of 0.68%, indicating higher-than-average management fees.
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of €10,000 in Global X China Biotech UCITS ETF USD Accumulating, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Global X China Biotech UCITS ETF USD Accumulating had a return of -12.36% year-to-date (YTD) and -24.44% in the last 12 months.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | -12.36% | 7.50% |
| 1 month | 6.74% | -1.61% |
| 6 months | -19.73% | 17.65% |
| 1 year | -24.44% | 26.26% |
| 5 years (annualized) | N/A | 11.73% |
| 10 years (annualized) | N/A | 10.64% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -21.39% | 11.02% | -5.03% | 1.95% | ||||||||
| 2023 | 4.99% | 2.37% | -10.48% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of CBI0.DE is 3, indicating that it is in the bottom 3% of the market in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.
Global X China Biotech UCITS ETF USD Accumulating(CBI0.DE)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Global X China Biotech UCITS ETF USD Accumulating (CBI0.DE) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Global X China Biotech UCITS ETF USD Accumulating. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Global X China Biotech UCITS ETF USD Accumulating was 54.33%, occurring on Feb 2, 2024. The portfolio has not yet recovered.
The current Global X China Biotech UCITS ETF USD Accumulating drawdown is 46.43%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -54.33% | Mar 2, 2022 | 494 | Feb 2, 2024 | — | — | — |
| -17.77% | Feb 2, 2022 | 9 | Feb 14, 2022 | 11 | Mar 1, 2022 | 20 |
Volatility
Volatility Chart
The current Global X China Biotech UCITS ETF USD Accumulating volatility is 7.04%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.